Assessment Services Market

  The global liquid biopsy market size is expected to reach USD 7,645.0 Million in 2030 and register a revenue CAGR of 20.3% over the forecast period, according to the latest analysis by Emergen Research. Rise in demand for early cancer detection is a key factor driving global liquid biopsy market revenue growth. The  Liquid Biopsy market  report covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region. Available Sample Report in PDF Version@  https://www.emergenresearch.com/request-sample/34 Competitive Terrain: The global Liquid Biopsy industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dom...

  The global Operating Room Integration Systems Market is expected to reach USD 3,104.4 Million by 2027, according to a new report by Emergen Research. The growing worldwide need for customized medication and a rise in innovative technologies for healthcare in hospitals are driving the market growth. Operating rooms (OR) are becoming increasingly complex and congested due to the growing need for devices during operations, such as surgical lights, producing tables, and surgical displays. Operating room integration systems offer a solution to the issues faced by operating rooms. The new operating rooms contain centralized data and provide connections to audio and video, and monitors on all surgical instruments at the central command center, allowing the surgeon to conduct different duties effectively without the necessity of going past the operating rooms. Integration systems for operation rooms are configured for clinical operations to enhance workflows, operational support, and pee...

  The Global Food Cold Chain Market is projected to reach USD 526.00 billion in 2027. Technological innovation is expected to drive growth in packaging, processing and storage of seafood products. Incorporating and processing temperature-sensible goods with cold chain solutions has become a part of supply chain management. Increased trade in perishable goods is expected to fuel demand over the forecast period for these solutions. Cold chain companies are gradually embracing renewable energy technologies like wind and solar to reduce overall operating costs. The  Food Cold Chain market  report covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region. Available Sample Report in PDF Version@  https://www...

  The global Direct-to-Consumer Genetic Testing Market is forecasted to reach USD 3.33 Billion by 2027, according to a new report by Emergen Research. Increasing genetic disease incidence would fuel competition for direct-to-consumer genetic testing and accelerate market development across the expected timeframe. Increasing cases of hereditary disorders such as breast cancer, achondroplasia, colorectal cancer and other diseases have increased the need for cost-effective and reliable avenues of genetic testing in the healthcare industry. For reference, according to the World Cancer Research Fund (WCRF), more than 2 million new cancer cases were reported globally in 2018. Breast cancer is now considered to be the second most prevalent disease. The introduction of a superior standard and innovative direct-to-consumer genetic testing has significantly lowered mortality levels of people with cancer by maintaining diligence surveillance data even before the onset of the disease. The prec...

  The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes. The  Non-Invasive Prenatal Testing market  report covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technologic...

  The Global NGS Sample Preparation Market is projected to reach USD 6.63 billion in 2027. Numerous advantages of high-performance sequencing compared to other genetic technologies, such as microarray and sanger-seq, are among the main driving forces in the Next Generation Sequencing (NGS) industry. In addition, it is estimated that the availability of sampling techniques with low input DNA reduces overall costs is that, expanding the use of next-generation sequencing in various scientific and clinical applications. The  NGS Sample Preparation market  report covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region. Available Sample Report in PDF Version@  https://www.emergenresearch.com/request-sample...

  The global Next Generation Sequencing Market is expected to reach USD 23.59 Billion by 2027, according to a new report by Emergen Research. The benefits of high-performance sequencing compared to other generations, such as the sanger-seq and microarrays, are one of the main drivers of the Next Generation Sequencing (NGS) industry. Therefore, it is expected that the increased availability of low input DNA sampling methods would speed up the use of next-generation sequence across various clinical and research applications. The  Next-Generation Sequencing market  report covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region. Available Sample Report in PDF Version@  https://www.emergenresearch.com/req...

  The Global Newborn Screening Market is forecasted to reach USD 2.27 Billion by 2027, according to a new report by Emergen Research. Newborn screening tests in infants check for developmental, metabolic, and genetic abnormalities. Newborn screening includes more than 30 illnesses and conditions. Additionally, various governmental and non-profit agencies are primarily focusing on providing quality fetal and maternal care. Besides, the industry is expected to experience a boost in demand due to the involvement of federal bodies involved in coordinating awareness and quality control programs to imbibe confidence and low the number of deaths caused by negligence and non-screening. New treatments such as enzyme replacement therapy, hematopoietic stem cell transplant, gene therapy, and novel therapeutic drugs have allowed the inclusion of autoimmune disorders as possible candidates in NBS programs. The  Newborn Screening market  report covers the scope of individual applicatio...